This is a transcript of an online program, which may be found at: http://www.theheart.org/article/883817.do PCI vs CABG in Multivessel Disease PCI vs CABG in Multivessel Disease Chair William E Boden MD Clinical Chief, Division of Cardiovascular Medicine; Professor of Medicine and Public Health, University at Buffalo Schools of Medicine & Biomedical Sciences; Medical Director, Cardiovascular Services, Kaleida Health; Chief of Cardiology, Buffalo General and Millard Fillmore Hospitals, Buffalo, NY Panelists: Friedrich W Mohr MD Professor of Cardiac Surgery, University of Leipzig Heart Center, Leipzig, Germany Patrick W Serruys MD PhD Professor of Medicine and Interventional Cardiology, Thoraxcenter, Erasmus University, Rotterdam, The Netherlands Slide 1 William E Bod en, MD: Hello. I’m Bill Boden from the State University of New York at Buffalo, United States. I’d like to welcome you to our Spotlight, "PCI vs CABG Surgery in Multivessel Disease," in which we’ll discuss the late-breaking and important SYNTAX trial (Synergy between PCI with TAXUS and Cardiac Surgery) that was presented at the 2008 European Society of Cardiology Meeting in Munich. I’m joined today by the two senior investigators and study co-chairs of SYNTAX, Professor Patrick Serruys of the University of Erasmus in The Netherlands, and Friedrich Mohr, Professor of Cardiac Surgery at the University of Leipzig Heart Center in Germany. Patrick, Friedrich, welcome.